Diabetes and other coronary heart disease risk equivalents

Current Opinion in Lipidology

Volumn 12, Issue 4, 2001, Pages 425-431

  James, Richard W ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN;

CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; EXERCISE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LIPOPROTEINS; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0034914054     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200108000-00009     Document Type: Review

References (54)

1. Cardiovascular disease in diabetes mellitus type 2: A potential role for novel cardiovascular risk factors
2. Insulin and atheroma. 20-Yr perspective
3. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes
4. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study
5. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: The Kuopio Ischaemic Heart Disease Risk Factor Study
6. Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The insulin Resistance Atherosclerosis Study)
7. Diabetes mellitus: Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortally
8. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study
9. Hypertriglyceridemia as a cardiovascular risk factor
10. Are postprandial triglyceride and insulin abnormalities neglected cardiovascular risk factors in type 2 diabetes?
11. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease
12. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: Relations to engiographically verified severity of coronary artery disease
13. Lipids and lipoproteins in women
14. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men
15. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes
16. Management of type 2 diabetes mellitus and cardiovascular risk: Lessons from intervention trials
17. Need for large scale rendomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials
18. Hypertriglyceridemia and the fibrate trials
19. Status report of lipid-lowering trials in diabetes
20. The Finnish Diabetes Prevention Study
21. Physical activity and risk for cardiovascular events in diabetic women
22. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes
23. Nitric oxide-mediated metabolic regulation during exercise: Effects of training in health and cardiovascular disease
24. Antioxidants, diabetes and endothelial dysfunction
25. Association between physical activity and markers of inflammation in a healthy elderly population
26. Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men
27. Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis
28. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: A 15-year follow-up from the time of diagnosis
29. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study
30. Lipoprotein concentrations and carotid atherosclerosis by diabetes status: Results from the Insulin Resistance Atherosclerosis Study
31. Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation
32. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics
33. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: Relevance to variation in risk of diabetes and coronary disease
34. Impact of diabetes on coronary artery disease in women and men: A meta-analysis of prospective studies
35. Evidence that triglycerides are an independent coronary heart disease risk factor
36. Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: A sex analysis
37. Type II diabetes abrogates sex differences in endothelial function in premenopausal women
38. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
39. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance
40. Insulin resistance affects endothelium-dependent acetylcholine-induced coronary artery response
41. Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease
42. Endothelial dysfunction: Cause of the insulin resistance syndrome
43. Insulin therapy improves endothelial function in type 2 diabetes
44. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
45. Short-term oral ascorbic acid improves endothelium-dependent vasodilatation in women with a history of gestational diabetes mellitus
46. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus
47. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits
48. Coronary artery injury and the biology of atherosclerosis: Inflammation, thrombosis, and stabilization
49. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
50. Risk factors for coronary heart disease in diabetes
51. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: The Hoorn study
52. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
53. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn Study
54. Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients